Compare Cheniere Energy (LNG) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cheniere Energy vs Mesoblast Limited — how do they compare? Cheniere Energy trades at $278.18 (market cap $57.39B), while Mesoblast Limited trades at $14.29 (market cap $1.75B). The key difference: Cheniere Energy is far larger — about 32.8× Mesoblast Limited's market cap, and Cheniere Energy pays a 0.8% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cheniere Energy for 10 Days and Mesoblast Limited for 15 Days on average.
| LNG | MESO | |
|---|---|---|
Market Cap | $57.39B | $1.75B |
Volume | 1,215,835 | 239,027 |
Sector | Energy | Health |
52-Week High | $296.91 | $20.96 |
52-Week Low | $188.83 | $13.19 |
Typical Hold Time | 10 Days | 15 Days |
Enterprise Value | $82.85B | $1.83B |
Dividend Yield | 0.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MESO trades at $13.75, down 1.36% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $102.14 million in 2025, though revenue grew to $120 million in 2026. Recent milestones include FDA approval for a new potency assay and completion of a Phase 3 trial for chronic low back pain, signaling progress in its commercial pipeline.
The outlook is mixed; analyst consensus leans buy (45% buy ratings), but profitability remains a challenge with negative margins. Key risks include high cash burn and competitive pressures, while catalysts hinge on successful commercialization of RYONCIL and upcoming trial results. The stock presents a high-risk, high-reward opportunity in the biotech sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Cheniere Energy
Cheniere Energy produces, liquefies, and exports natural gas as liquefied natural gas, or LNG. It operates large-scale LNG infrastructure along the U.S. Gulf Coast.
Read more on LNG →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
